Blog

Postpartum depression (PPD) is a serious mood disorder that can affect women after childbirth. Unlike the more common and temporary "baby blues," which typically resolve within two weeks, postpartum depression can last much longer and significantly impact a mother’s ability to care for herself and her baby. Learn more.

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. Host: Anthony Effinger Subscribe: Apple Podcasts | Spotify | Simplecast Watch on YouTube: Click Here 63. The Psychedelic Renaissance Turns...

The Food and Drug Administration recently approved the nasal spray Spravato (esketamine) for the treatment of MDD in those who have not responded to at least two oral antidepressants. Learn more.

This episode of the ThinkNeuro Podcast features Dr. Jennifer Bramen, a neuroscientist at Pacific Neuroscience Institute, as she explores the powerful connection between gut microbes and brain health. Discover how the gut’s nervous system and its bacteria impact our mood and stress levels, and learn practical tips on how to support a healthy gut-brain connection through mindful eating. Tune in to hear Dr. Bramen's insights and research on this fascinating topic.

Preparation for ketamine-assisted psychotherapy (KAP) involves several key components aimed at ensuring the safety and efficacy of the treatment, as well as preparing the patient mentally and emotionally for the experience. Keep reading.

In recent years, ketamine-assisted psychotherapy (KAP) has emerged as a promising treatment for various mental health conditions, offering new hope to individuals who have not found relief through conventional therapies. Learn more.

This episode of the ThinkNeuro Podcast join us as we delve into this paradigm shift, uncovering how PNI is blazing a trail in the realm of psychedelic-assisted therapies.

Ketamine-assisted psychotherapy (KAP) is emerging as a significant therapeutic approach for various mental health conditions. However, the efficacy of KAP is greatly enhanced when coupled with a crucial component: integration. Learn how Pacific Neuroscience Institute® (PNI®)'s Treatment & Research in Psychedelics (TRIP) Center uses integration to optimize patient outcomes.

Explore the transformative benefits of ketamine therapy in treating treatment-resistant depression, anxiety disorders, PTSD, chronic pain, and addiction. Learn how Pacific Neuroscience Institute's expert team harnesses the potential of ketamine to offer hope and relief.

Immersive nature videos may enhance psychedelic-assisted therapy for alcohol addiction, according to research by Pacific Neuroscience Institute and renowned filmmaker Louie Schwartzberg.